RESUMO
The lipid endocannabinoid system has recently emerged as a novel therapeutic target for several inflammatory and tissue-damaging diseases, including those affecting the cardiovascular system. The primary targets of cannabinoids are cannabinoid type 1 (CB1) and 2 (CB2) receptors. The CB2 receptor is expressed in the cardiomyocytes. While the pathological changes in the myocardium upregulate the CB2 receptor, genetic deletion of the receptor aggravates the changes. The CB2 receptor plays a crucial role in attenuating the advancement of myocardial infarction (MI)-associated pathological changes in the myocardium. Activation of CB2 receptors exerts cardioprotection in MI via numerous molecular pathways. For instance, delta-9-tetrahydrocannabinol attenuated the progression of MI via modulation of the CB2 receptor-dependent anti-inflammatory mechanisms, including suppression of pro-inflammatory cytokines like IL-6, TNF-α, and IL-1ß. Through similar mechanisms, natural and synthetic CB2 receptor ligands repair myocardial tissue damage. This review aims to offer an in-depth discussion on the ameliorative potential of CB2 receptors in myocardial injuries induced by a variety of pathogenic mechanisms. Further, the modulation of autophagy, TGF-ß/Smad3 signaling, MPTP opening, and ROS production are discussed. The molecular correlation of CB2 receptors with cardiac injury markers, such as troponin I, LDH1, and CK-MB, is explored. Special attention has been paid to novel insights into the potential therapeutic implications of CB2 receptor activation in MI.
Assuntos
Canabinoides , Infarto do Miocárdio , Receptor CB1 de Canabinoide , Humanos , Canabinoides/farmacologia , Canabinoides/uso terapêutico , Canabinoides/metabolismo , Endocanabinoides/metabolismo , Infarto do Miocárdio/tratamento farmacológico , Infarto do Miocárdio/genética , Infarto do Miocárdio/metabolismo , Miocárdio/metabolismo , Receptor CB1 de Canabinoide/genética , Receptor CB1 de Canabinoide/metabolismo , Receptor CB2 de Canabinoide/genética , Receptor CB2 de Canabinoide/metabolismo , Receptores de Canabinoides/metabolismo , Dronabinol/farmacologiaRESUMO
A comprehensive study regarding the effect of different solvent vapours on organolead halide perovskite properties is lacking. In the present work, the impact of exposing CH3NH3PbI3 films to the vapours of commonly available solvents has been studied. The interaction with perovskite has been correlated to solvent properties like dielectric constant, molecular dipole moment, Gutmann donor number and boiling point. Changes in the crystallinity, phase, optical absorption, morphologies at both nanometer and micrometer scale, functional groups and structures were studied using X-ray diffraction, UV-visible absorption, FE-SEM, FTIR and Raman spectroscopies. Among the aprotic solvents DMSO and DMF vapours deteriorate the crystallinity, phase, and optical, morphological and structural properties of the perovskite films in a very short time, but due to the difference in solvent property values acetone affects the perovskite properties differently. Polar protic 2-propanol and water vapours moderately affect the perovskite properties. However 2-propanol can solvate the organic cation CH3NH3 + more efficiently as compared to water and a considerable difference was found in the film properties especially the morphology at the nanoscale. Nonpolar chlorobenzene vapour minutely affects the perovskite morphology but toluene was found to enhance perovskite crystallinity. Solvent properties can be effectively used to interpret the coordination ability of a solvent. The present study can be immensely useful in understanding the effects of different solvent vapours and also their use for post-deposition processing (like solvent vapour annealing) to improve their properties.
